Add
IMMU to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| IMMU > SEC Filings for IMMU > Form 8-K on 27-Feb-2013 | All Recent SEC Filings |
27-Feb-2013
Other Events, Financial Statements and Exhibits
On February 27, 2013, Immunomedics, Inc., a Delaware corporation (the "Company"), issued a press release announcing that the Company has completed its previously announced sale of an aggregate of 6,086,956 shares of common stock pursuant to the Company's existing shelf registration statement (File No. 333-184377) on Form S-3. In addition, the Company announced the exercise of the underwriters' overallotment option to purchase 913,044 shares of the Company's common stock. The sale of the additional shares by the Company upon the exercise of the over-allotment option also closed on February 27, 2013. In the aggregate, the Company received total proceeds of approximately $14.8 million, based on a public offering price of $2.30 per share, after deducting the underwriting discounts and commissions and estimated expenses related to the offering payable by the Company. Oppenheimer & Co. Inc. and Cowen and Company, LLC served as the joint book-running managers.
Exhibits.
Exhibit
No. Description
99.1 Press Release of the Company dated February 27, 2013.
|
|